Author: Brian Wu, MD candidate, Keck School of Medicine, Los Angeles, USA. DermNet New Zealand Editor in Chief: Hon A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand. December 2016.
Buschke–Ollendorff syndrome refers to a rare, hereditary disorder affected the connective tissues. It is also known as dermatofibrosis lenticularis disseminata, dermato-osteopoikilosis and familialcutaneous collagenoma.
Who gets Buschke–Ollendorff syndrome?
Buschke–Ollendorff syndrome occurs in 1 in every 20,000 live births worldwide. There appears to be no racial, sexual or geographical predilection.Lesions are present at birth.
What causes Buschke–Ollendorff syndrome?
Buschke–Ollendorff syndrome is a genetic disease. The underlying cause of Buschke–Ollendorff syndrome is mutation of the LEMD3gene, which provides instructions for the making of proteins that support connective tissues.
Inheritance is in an autosomal dominant pattern with incomplete penetrance. The child of someone with the syndrome has a 50% chance of inheriting the faulty LEMD3gene but may not actually develop the syndrome.
It may result from abnormal regulation of the extracellular matrix, which results in a build-up of elastin in the dermal layer of skin.
What are the clinical features of Buschke–Ollendorff syndrome?
Surgical or other treatment of associated disorders, such as diabetes mellitus or aortic stenosis.
What is the outcome for Buschke–Ollendorff syndrome?
The outcome for Buschke–Ollendorff syndrome depends on the associated disorders.
A leading cause of mortality related to Buschke–Ollendorff syndrome is the development of areas of bone density into bone cancers such as osteosarcoma, chondrosarcoma or giant celltumours.
When other disorders like aortic stenosis or diabetes mellitus are present, the prognosis can be serious.